TScan Therapeutics Announces Pioneering Publication in Scientific Journal Cell Describing New Methods to Identify Targets for T Cell Receptor Immunotherapy August 12, 2019
Verastem Oncology Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress August 12, 2019
Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update August 12, 2019
TScan Therapeutics Formed to Overcome Challenges of Current Immunotherapies with Novel TCR Discovery Platform and $48 Million in Funding July 24, 2019
